BioMarin Pharmaceutical
$67.09
24H
Market Cap
Volume
Supply
Price Chart
About BioMarin Pharmaceutical - BMRN
BioMarin Pharmaceutical Inc. is a biotechnology company that specializes in developing and commercializing innovative therapies for rare genetic diseases. They are known for their focus on conditions that have limited treatment options, such as hemophilia, Pompe disease, and various metabolic conditions.
What are BioMarin Pharmaceutical's core values and mission statement?
BioMarin Pharmaceutical Inc.'s mission is to develop and deliver innovative therapies that address serious and life-threatening rare disorders. Their core values emphasize a commitment to patients, science-driven innovation, integrity, and a dynamic and caring work environment.
Who founded BioMarin Pharmaceutical and when?
BioMarin Pharmaceutical Inc. was founded by Christopher Starr, Ph.D., and Grant W. Denison Jr. in 1997.
Who leads BioMarin Pharmaceutical?
BioMarin Pharmaceutical Inc. is led by its CEO, Jean-Jacques Bienaimé.
Where is BioMarin Pharmaceutical located, and what is its base country?
BioMarin Pharmaceutical Inc. is headquartered in San Rafael, California, and is based in the United States.
On which exchanges is BioMarin Pharmaceutical traded?
BioMarin Pharmaceutical Inc. is traded on the Nasdaq Stock Market under the ticker symbol BMRN.
Historical data
BioMarin Pharmaceutical (BMRN) Price Live Data
The live price of BioMarin Pharmaceutical (BMRN) is $67.09, with a trading volume of 655,864 in the last 24 hours. Wrapstocks updates the BMRN price in real-time. BioMarin Pharmaceutical is up 0.22% in the last 24 hours. The company has a live market cap of $12,786,212,864.00 and a supply of 190,582,991 BMRN stocks.
BioMarin Pharmaceutical (BMRN) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 4 hours and 13 minutes.
